Pharmafile Logo
Pharmafocus logo
Advanced Search

ImmTAC deal for Immunocore

June 27, 2013
Research and Development, Sales and Marketing Genentech, ImmTAC, oxford biotech

Oxford-based biotech company Immunocore has signed what could be a $300 million deal with Genentech to discover and bring to …

News
bryan_morton

Oxford BioTherapeutics hires chairman

June 27, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Oxford Biotherapeutics, morton

Biotech firm Oxford BioTherapeutics has appointed Bryan Morton to be the company’s new non-executive chairman. Morton has over 30 years’ …

Appointment

Contract research news in brief

June 27, 2013
Research and Development PRA International, Parexel, Quanticate, TKL, WIL Research

A round-up of recent developments in the contract research sector, including KKR’s acquisition of PRA, a new Parexel business unit …

News
Cytokinetics image

Astellas in $500m deal with Cytokinetics

June 27, 2013
Sales and Marketing Astellas, cytokinetics

Astellas Pharma could pay out $40 million over the next two years to US firm Cytokinetics as part of a …

News

Heart failure treatment given Breakthrough Status

June 27, 2013
Sales and Marketing Breakthrough Therapy Designation, Novartis, RLX03O, serelaxin

Novartis’ new treatment for heart failure has been granted Breakthrough Therapy designation status by the FDA. RLX030 (serelaxin) is for …

News

Xtandi gets EU approval

June 26, 2013
Sales and Marketing Astellas, FDA, Xtandi

Astellas Pharma’s Xtandi has been approved in the European Union for the treatment of adult men with advanced prostate cancer, …

News
evista image

NICE finalises tamoxifen guidance

June 26, 2013
Sales and Marketing Evista, NICE, lilly, tamoxifen

Women at risk of breast cancer can now be offered a daily pill on the NHS to stop the disease …

News
douglas_ingram_allergan

Allergan announces new president

June 26, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, ingram

Allergan has hired Douglas Ingram to be its president and lead the company’s global commercial operations. In this newly established …

Appointment
Sanofi image

Sanofi chief executive to lead EFPIA

June 26, 2013
Research and Development, Sales and Marketing EFPIA, GSK, Sanofi, Viehbacher, Witty

Chief executive of Sanofi Christopher Viehbacher has been elected to serve as president of the European Federation of Pharmaceutical Industries …

News
Ranbaxy image

Ranbaxy facing another facility problem?

June 26, 2013
Manufacturing and Production FDA, Ranbaxy

Another facility operated by Ranbaxy Laboratories in India is reported to have failed an inspection by the FDA, potentially adding …

News
Forxiga image

NICE completes Forxiga U-turn

June 26, 2013
Sales and Marketing BMS, Forxiga, NICE

Bristol-Myers Squibb and AstraZeneca are celebrating after NICE reversed its decision from earlier this year and is now recommending their …

News
Merck Serono image

Merck Serono censured over calls

June 25, 2013
Medical Communications, Sales and Marketing ABPI, Erbitux, Merck Serono, PMCPA

A Merck Serono medical representative has been accused of ‘harassing’ an anonymous health professional by requesting a meeting every month …

News
Lilly image

Lilly diabetes drug beats rivals

June 25, 2013
Sales and Marketing BMS, diabetes, dulaglutide, lilly

New clinical trial results have shown Lilly’s investigational type 2 diabetes drug has beaten its three nearest rivals in reducing …

News
rodgergraham

Roger Graham appointed president of Mylan Specialty

June 25, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Mylan, graham, specialty

Mylan has hired previous J&J vice president Roger Graham to be president of its specialty business. Graham will report to …

Appointment
FDA Hamburg image

US gains exemption from EU requirements on API imports

June 25, 2013
Manufacturing and Production API, FDA, hamburg

The US has joined the short list of countries from which suppliers can ship active pharmaceutical ingredients into the EU …

News
GSK image

GSK mulling sales of thrombosis brands and facility to Aspen

June 24, 2013
Manufacturing and Production, Sales and Marketing Arixtra, GSK, aspen

GlaxoSmithKline says it is considering an offer from South African drugmaker Aspen Pharmacare to take ownership of two thrombosis drugs …

News
dinesh_c

BMS appoints Harman International chief executive

June 24, 2013
Manufacturing and Production, Research and Development, Sales and Marketing BMS

Bristol-Myers Squibb has appointed Harman’s chief executive Dinesh Paliwal to its Board of directors.Paliwal will serve as a member of …

Appointment

Viagra patent expiry opens up market

June 24, 2013
Manufacturing and Production, Research and Development, Sales and Marketing ED, Pfizer, generics, viagra

Pfizer lost its UK patent rights to its erectile dysfunction drug Viagra over the weekend, leading to an influx of …

News

Lundbeck cuts more jobs in Europe

June 24, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Lexapro, Lundbeck, cuts

Lundbeck is to cut yet more jobs in Europe as the Danish pharma firm restructures its operations to focus on …

News
Haslam image

David Haslam: a new chairman for a new NICE

June 24, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Hasmam, NHS, NICE

When NICE was first set up in 1999, technology appraisals of new medicines were its sole focus, but over the …

Feature
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026